Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

560
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
560
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.1K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

822
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
822

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum Palmitoleic Acid and Arachidonic Acid as a Noninvasive Screening Tool for Endometrial Cancer.

Cancers·2026
Same author

Evaluation of Tilt and Decentration of Intraocular Lens After Combined Femtosecond Laser-Assisted Cataract Surgery and Vitrectomy.

Journal of ophthalmology·2026
Same author

Nationwide trends in outpatient rates for ophthalmic surgeries in Japan before and after the COVID-19 pandemic: an analysis of the NDB open data.

Scientific reports·2026
Same author

Lens epithelial cell damage and reduced aquaporin-1 immunoreactivity in liquefied mature cataracts.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Association between the anatomical location of conjunctivochalasis and subjective symptoms: a multicenter retrospective study.

Japanese journal of ophthalmology·2026
Same author

Bilateral Acute Retinal Pigment Epitheliitis Diagnosed and Monitored Using Multimodal Imaging: A Case Report.

Cureus·2026

Related Experiment Video

Updated: Dec 31, 2025

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
07:49

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Published on: September 17, 2014

11.8K

Electroretinographic abnormalities associated with pregabalin: a case report.

Wakana Ninomiya1, Kei Mizobuchi1, Takaaki Hayashi2,3

  • 1Department of Ophthalmology, The Jikei University School of Medicine, Tokyo, Japan.

Documenta Ophthalmologica. Advances in Ophthalmology
|January 5, 2020
PubMed
Summary

Pregabalin treatment may cause electroretinographic abnormalities, affecting vision. These changes, observed in a case report, improved after discontinuing the medication, suggesting a link to retinal function.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Pharmacology

Background:

  • Pregabalin is known to bind to voltage-gated calcium channel subunits (α2-δ1/α2-δ2).
Keywords:
Electronegative wave formFull-field electroretinographyL-type calcium channelOcular adverse eventPregabalin

More Related Videos

Simultaneous Recording of Electroretinography and Visual Evoked Potentials in Anesthetized Rats
10:30

Simultaneous Recording of Electroretinography and Visual Evoked Potentials in Anesthetized Rats

Published on: July 1, 2016

12.8K
Direct-Coupled Electroretinogram DC-ERG for Recording the Light-Evoked Electrical Responses of the Mouse Retinal Pigment Epithelium
09:10

Direct-Coupled Electroretinogram DC-ERG for Recording the Light-Evoked Electrical Responses of the Mouse Retinal Pigment Epithelium

Published on: July 14, 2020

5.7K

Related Experiment Videos

Last Updated: Dec 31, 2025

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
07:49

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Published on: September 17, 2014

11.8K
Simultaneous Recording of Electroretinography and Visual Evoked Potentials in Anesthetized Rats
10:30

Simultaneous Recording of Electroretinography and Visual Evoked Potentials in Anesthetized Rats

Published on: July 1, 2016

12.8K
Direct-Coupled Electroretinogram DC-ERG for Recording the Light-Evoked Electrical Responses of the Mouse Retinal Pigment Epithelium
09:10

Direct-Coupled Electroretinogram DC-ERG for Recording the Light-Evoked Electrical Responses of the Mouse Retinal Pigment Epithelium

Published on: July 14, 2020

5.7K
  • These subunits are expressed in the terminals of rod and cone photoreceptors in the retina.
  • Potential ocular side effects of pregabalin are not well-documented.